Related Experiment Videos
Mycobacterium tuberculosis susceptibility in Saudi Arabia
Abdulrahman A Alrajhi1, Ali M Al-Barrak
1Section of Infectious Diseases, Department of Medicine, King Faisal Specialist Hosptial and Research Centre, Riyadh, Kingdom of Saudi Arabia. rajhi@kfshrc.edu.sa
Saudi Medical Journal
|November 19, 2002
Summary
Tuberculosis drug resistance is high in the Kingdom of Saudi Arabia (KSA), with 18.4% of Mycobacterium tuberculosis isolates resistant to at least one first-line agent. Multidrug-resistant tuberculosis was found in 5.7% of cases, highlighting the need for monitoring programs.
Area of Science:
- Microbiology
- Public Health
- Epidemiology
Background:
- Tuberculosis remains a significant global health challenge.
- Drug resistance in Mycobacterium tuberculosis complicates treatment and control efforts.
- Limited comprehensive data exists on drug susceptibility patterns in the Kingdom of Saudi Arabia (KSA).
Purpose of the Study:
- To synthesize and present available susceptibility data for Mycobacterium tuberculosis isolates from KSA.
- To analyze resistance patterns to first-line anti-tuberculosis agents.
- To identify trends and regional variations in drug resistance.
Main Methods:
- A meta-analysis was conducted on peer-reviewed studies published between 1966 and 2001.
- Data from Medline-indexed and non-indexed publications were included.
- Isolates' growth and resistance numbers for first-line agents were tabulated.
Main Results:
- Twelve studies comprising 6,316 Mycobacterium tuberculosis isolates (1979-2000) were analyzed.
- Overall resistance to at least one first-line agent was 18.4%.
- Monoresistance (10.9%), polyresistance (7.6%), and multidrug resistance (5.7%) were observed. Isoniazid resistance was most prevalent (11%).
- Resistance rates showed no significant statistical difference between 1979-1991 and 1989-2000.
- Higher resistance rates were noted in the Western and Southern regions of KSA.
Conclusions:
- High rates of resistance to first-line anti-tuberculosis agents and multidrug-resistant tuberculosis exist in KSA.
- These findings underscore the urgent need for robust drug-resistant tuberculosis surveillance and monitoring programs.
- Community-level resistance data is crucial for effective public health interventions.